ID   L5178Y BLM-A2-R
AC   CVCL_UZ88
DR   Wikidata; Q95981026
RX   PubMed=6173370;
CC   Doubling time: 14.7 hours (PubMed=6173370).
CC   Selected for resistance to: ChEBI; CHEBI_3139; Bleomycin A2.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the resistance phenotype.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
RX   PubMed=6173370; DOI=10.7164/antibiotics.34.1210;
RA   Suzuki H., Nishimura T., Tanaka N.;
RT   "Drug sensitivity and some characteristics of a bleomycin-resistant
RT   subline of mouse lymphoblastoma L5178Y cells.";
RL   J. Antibiot. 34:1210-1212(1981).
//